ImmunologybioRxivPreprint
EBV Type 1 versus Type 2: A determinant of NK cell anti-tumor activity in Burkitt lymphoma
Catherine Suzanne Forconi, Lauren Shumate, Zachary J. Racenet…·Ann Marie Moormann
This study compares ADCC activity of CD56neg and CD56dim NK cells against EBV-type 1 and 2 Burkitt lymphoma cells, finding EBV-T2 cells are more susceptible to direct cytotoxicity.
DOI 10.64898/2026.02.09.704808